Latest filings (excl ownership)
6-K/A
Current report (foreign) (amended)
24 Jun 24
6-K
Current report (foreign)
20 Jun 24
6-K
Current report (foreign)
24 May 24
6-K/A
Current report (foreign) (amended)
25 Apr 24
6-K
Current report (foreign)
24 Apr 24
20-F
2023 FY
Annual report (foreign)
22 Apr 24
6-K
CytoMed Therapeutics to Launch Complimentary Cell Banking for Qualified Shareholders for Future Precision Therapies
18 Mar 24
6-K
Current report (foreign)
4 Mar 24
6-K
Malaysian Patent Granted for CytoMed Therapeutics’ Licensed Allogeneic CAR-Gamma Delta T Cell Technology
29 Jan 24
6-K
Current report (foreign)
17 Nov 23
6-K
Chinese Patent Granted for CytoMed Therapeutics’ Licensed iPSC-based Technology
25 Sep 23
6-K
Chinese Patent Granted for A*STAR Spinoff, CytoMed Therapeutics’ Licensed Allogeneic CAR-Gamma Delta T Cell Technology
1 Aug 23
6-K
A*STAR Spinoff CytoMed Therapeutics Announce a Patent for its Licensed CAR-Gamma Delta T Cell Technology Has Been Granted in the US
6 Jul 23
20-F
2022 FY
Annual report (foreign)
1 May 23
6-K
Cytomed Therapeutics Limited Announces Pricing of Initial Public Offering
18 Apr 23
424B4
Prospectus supplement with pricing info
17 Apr 23
CERT
Certification of approval for exchange listing
14 Apr 23
EFFECT
Notice of effectiveness
3 Apr 23
FWP
Free writing prospectus
31 Mar 23
CORRESP
Correspondence with SEC
31 Mar 23
CORRESP
Correspondence with SEC
31 Mar 23
CORRESP
Correspondence with SEC
31 Mar 23
SEC STAFF
SEC staff action: Order
31 Mar 23
8-A12B
Registration of securities on exchange
30 Mar 23
F-1/A
Registration statement (foreign) (amended)
30 Mar 23
CORRESP
Correspondence with SEC
30 Mar 23
UPLOAD
Letter from SEC
29 Mar 23
F-1/A
Registration statement (foreign) (amended)
27 Mar 23
F-1/A
Registration statement (foreign) (amended)
15 Mar 23
CORRESP
Correspondence with SEC
15 Mar 23
FWP
Free writing prospectus
27 Feb 23
UPLOAD
Letter from SEC
24 Feb 23
F-1/A
Registration statement (foreign) (amended)
21 Feb 23
CORRESP
Correspondence with SEC
21 Feb 23
UPLOAD
Letter from SEC
9 Feb 23
F-1/A
Registration statement (foreign) (amended)
31 Jan 23
CORRESP
Correspondence with SEC
31 Jan 23
SEC STAFF LETTER
SEC staff letter
30 Nov 22
UPLOAD
Letter from SEC
30 Nov 22
F-1
Registration statement (foreign)
18 Nov 22
Latest ownership filings
SC 13G/A
Choo Chee Kong
23 May 24
SC 13G
Choo Chee Kong
14 Feb 24
SC 13G
mDR Ltd
14 Feb 24
SC 13G
Zeng Jieming
14 Feb 24
SC 13G
Wang Shu
14 Feb 24
SC 13D
Zeng Jieming
19 May 23
SC 13G
mDR Ltd
24 Apr 23
SC 13D
Choo Chee Kong
21 Apr 23
3
Yuin Han Loh
17 Apr 23
3
Mark Kei Wei Leong
17 Apr 23
3
Jieming Zeng
14 Apr 23
3
Keng Kiat Toh
14 Apr 23
3
Chee Kong Choo
14 Apr 23
3
Lucas Tien Wee Luk
14 Apr 23
3
Chak Hua Yew
14 Apr 23
3
Wee Kiat Tan
14 Apr 23
3
Shu Wang
14 Apr 23
3
Initial statement of insider ownership
14 Apr 23